Ligand Pharmaceuticals Incorporated (LGND) stock
Price, quality score, analyst targets, a 30-day Kronos AI forecast and a Shariah screen for Ligand Pharmaceuticals Incorporated, updated every trading day.
Health Care · Biotechnology: Pharmaceutical Preparations
Price
$318.78
+2.26% today
Market cap
$6.2B
Overall quality
—
Kronos AI 30-day
−11.5%
0 of 8 simulated paths end higher
Ligand Pharmaceuticals Incorporated (LGND) is a Health Care company in Biotechnology: Pharmaceutical Preparations, worth $6.2B. It trades at $318.78, up 2.26% today. 8 analysts' average target of $362.83 implies +13.8% from today's price. Kronos AI's 30-day forecast is −11.5% (0 of 8 simulated paths end higher).
Open the full interactive analysis →Charts, technical signals, DCF fair value and ownership
Analyst price targets
| Average target | $362.83 |
| Low – high | $326.00 – $406.00 |
| Analysts | 8 |
| Upside to average | +13.8% |
Kronos AI 30-day forecast
| Expected close | $276.02 (−11.5%) |
| Likely range | −16.1% … −4.5% |
| As of | 2026-10-27 |
0 of 8 simulated paths end higher.
Quality scores
Not scored: the financial data for this listing is incomplete.
Shariah screen
| Business activity | Passes |
| Debt and cash (AAOIFI 30%) | Not checked for this listing |
Automated screen of business activity and AAOIFI's 30% debt and cash limits. The 5% impermissible-income test is not applied. Check with a scholar before deciding.
Similar companies in Biotechnology: Pharmaceutical Preparations
For information only, not investment advice. Prices updated: 2026-10-29.